skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Female remover Breast Neoplasms - Drug Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust

Piccart, M.J. ; Kalinsky, K. ; Gray, R. ; Barlow, W.E. ; Poncet, C. ; Cardoso, F. ; Winer, E. ; Sparano, J.

Annals of oncology, 2021-09, Vol.32 (9), p.1077-1082 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Research needs in breast cancer
Research needs in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Research needs in breast cancer

Cardoso, F. ; Harbeck, N. ; Barrios, C.H. ; Bergh, J. ; Cortés, J. ; El Saghir, N. ; Francis, P.A. ; Hudis, C.A. ; Ohno, S. ; Partridge, A.H. ; Sledge, G.W. ; Smith, I.E. ; Gelmon, K.A.

Annals of oncology, 2017-02, Vol.28 (2), p.208-217 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers
Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant treatment for HER-2-positive and triple-negative breast cancers

Sousa, B ; Cardoso, F

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x237-x242 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
4
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Viale, G. ; Slaets, L. ; Bogaerts, J. ; Rutgers, E. ; van't Veer, L. ; Piccart-Gebhart, M.J. ; de Snoo, F.A. ; Stork-Sloots, L. ; Russo, L. ; Dell'Orto, P. ; van den Akker, J. ; Glas, A. ; Cardoso, F.

Annals of oncology, 2014-04, Vol.25 (4), p.816-823 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria

Gao, J.J. ; Krol, D. ; Narayan, P. ; Cardoso, F. ; Regan, M.M. ; Goetz, M.P. ; Hurvitz, S.A. ; Mauro, L. ; Hodgdon, C. ; Miller, C.P. ; Booth, B. ; Bloomquist, E. ; Ison, G. ; Osgood, C. ; Bhatnagar, V. ; Fashoyin-Aje, L. ; Pazdur, R. ; Amiri-Kordestani, L. ; Beaver, J.A.

Annals of oncology, 2021-08, Vol.32 (8), p.950-953 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

Annals of oncology, 2013-12, Vol.24 (12), p.2985-2989 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Cardoso, F. ; Costa, A. ; Norton, L. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Biganzoli, L. ; Blackwell, K.L. ; Cardoso, M.J. ; Cufer, T. ; El Saghir, N. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Giordano, S.H. ; Gligorov, J. ; Goldhirsch, A. ; Harbeck, N. ; Houssami, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Kyriakides, S. ; Lin, U.N. ; Mayer, M. ; Merjaver, S.D. ; Nordström, E.B. ; Pagani, O. ; Partridge, A. ; Penault-Llorca, F. ; Piccart, M.J. ; Rugo, H. ; Sledge, G. ; Thomssen, C. ; van't Veer, L. ; Vorobiof, D. ; Vrieling, C. ; West, N. ; Xu, B. ; Winer, E.

Annals of oncology, 2014-10, Vol.25 (10), p.1871-1888 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer

Azambuja, E. ; Durbecq, V. ; Rosa, D. D. ; Colozza, M. ; Larsimont, D. ; Piccart-Gebhart, M. ; Cardoso, F.

Annals of oncology, 2008-02, Vol.19 (2), p.223-232 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

CARDOSO, F ; DI LEO, A ; LOHRISCH, C ; BERNARD, C ; FERREIRA, F ; PICCART, M. J

Annals of oncology, 2002-02, Vol.13 (2), p.197-207 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
Recent advances in adjuvant systemic therapy for early-stage breast cancer
Recent advances in adjuvant systemic therapy for early-stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recent advances in adjuvant systemic therapy for early-stage breast cancer

Bedard, P. L. ; Cardoso, F.

Annals of oncology, 2008-07, Vol.19 (suppl-5), p.v122-v127 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.